Arcadia Biosciences, Inc. (NASDAQ:RKDA) Sees Large Drop in Short Interest

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the recipient of a large drop in short interest in the month of July. As of July 31st, there was short interest totaling 3,495 shares, a drop of 63.8% from the July 15th total of 9,653 shares. Based on an average trading volume of 15,605 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.2% of the shares of the company are sold short.

Arcadia Biosciences Stock Performance

Shares of NASDAQ:RKDA traded up $0.04 during mid-day trading on Friday, hitting $0.61. The stock had a trading volume of 73,183 shares, compared to its average volume of 1,273,635. The company’s 50 day moving average is $0.73 and its 200-day moving average is $1.21. The company has a market cap of $1.48 million, a PE ratio of -0.11 and a beta of 0.56. Arcadia Biosciences has a 12-month low of $0.50 and a 12-month high of $6.71.

Arcadia Biosciences (NASDAQ:RKDA) last issued its quarterly earnings results on Thursday, August 13th. The basic materials company reported ($0.38) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.56) by $0.18. Arcadia Biosciences had a negative return on equity of 113.73% and a negative net margin of 195.94%.The business had revenue of $1.44 million for the quarter, compared to the consensus estimate of $1.90 million.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings lowered Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 25th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Arcadia Biosciences currently has a consensus rating of “Sell”.

About Arcadia Biosciences

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.